Awarded contractOpenSuppliesPoland

Produkty lecznicze

5 suppliers awarded•6 lots awarded•€628,113 awarded

Buyer: Szpital Specjalistyczny im. Jędrzeja Śniadeckiego / Nowy Sącz, Poland

Published Mar 19, 2024Awarded Jan 31, 2024

Medical equipments, pharmaceuticals and personal care productsGeneral anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Awarded value

€628.1K

Estimated value

€379.2K

Awarded at 166% of estimated value

Award date

Jan 31, 2024

Winners

Lots awarded

Award values

Notice total

€628.1K

Sum of lot awards

€225.1K

TED notice total and lot-level values do not exactly match.

Winners

AstraZeneca Kft.

Budapest, HUN

2 lots

€133,505 This contract

117 award notices•169 awarded lots•€88.72M total

AstraZeneca Kft.

Budapest, HUN

2 lots

€133,505 This contract

93 award notices•124 awarded lots•€55.56M total

Komtur Polska Sp. z o. o.

Warszawa, POL

1 lot

€52,917 This contract

74 award notices•123 awarded lots•€31.24M total

Asclepios S.A.

Wrocław, POL

1 lot

€18,387 This contract

101 award notices•181 awarded lots•€140.50M total

Janssen-Cilag Polska sp. z o.o.

Warszawa, POL

1 lot

€2,712 This contract

56 award notices•75 awarded lots•€33.29M total

Lots awarded

Lot	Winner	Award value	Main CPV
LOT-0001	AstraZeneca Kft.	€95,262	General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (33650000)
LOT-0004	Komtur Polska Sp. z o. o.	€52,917	General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (33650000)
LOT-0005	AstraZeneca Kft.	€38,243	General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (33650000)
LOT-0003	Asclepios S.A.	€18,387	General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (33650000)
LOT-0002	Not specified	€17,546	General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (33650000)
LOT-0006	Janssen-Cilag Polska sp. z o.o.	€2,712	General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents (33650000)